Balance Sheet
Cash Flow Statement
AcquisitionsBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENvue Medical (FEED) Cash from Investing Activities (2017 - 2025)

Historic Cash from Investing Activities for ENvue Medical (FEED) over the last 8 years, with Q3 2025 value amounting to -$28000.0.

  • ENvue Medical's Cash from Investing Activities changed N/A to -$28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $111000.0, marking a year-over-year increase of 380000.0%. This contributed to the annual value of -$3000.0 for FY2024, which is 20000.0% down from last year.
  • ENvue Medical's Cash from Investing Activities amounted to -$28000.0 in Q3 2025.
  • ENvue Medical's Cash from Investing Activities' 5-year high stood at $143000.0 during Q1 2025, with a 5-year trough of -$28000.0 in Q3 2025.
  • For the 5-year period, ENvue Medical's Cash from Investing Activities averaged around $10300.0, with its median value being -$1500.0 (2021).
  • In the last 5 years, ENvue Medical's Cash from Investing Activities plummeted by 10000.0% in 2022 and then surged by 1440000.0% in 2025.
  • ENvue Medical's Cash from Investing Activities (Quarter) stood at -$1000.0 in 2021, then surged by 200.0% to $1000.0 in 2022, then tumbled by 200.0% to -$1000.0 in 2023, then crashed by 100.0% to -$2000.0 in 2024, then tumbled by 1300.0% to -$28000.0 in 2025.
  • Its Cash from Investing Activities was -$28000.0 in Q3 2025, compared to -$4000.0 in Q2 2025 and $143000.0 in Q1 2025.